Laddar...

Towards personalized therapy for patients with glioblastoma

Combined therapy with temozolomide and radiotherapy is a standard treatment and improves the survival for patients with newly diagnosed glioblastoma. However, the prognosis remains poor, with a median survival time of 12–15 months. Currently, several clinical trials of dose-dense temozolomide regime...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Expert Rev Anticancer Ther
Huvudupphovsmän: Shirai, Katsuyuki, Chakravarti, Arnab
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2011
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4297206/
https://ncbi.nlm.nih.gov/pubmed/22117160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/era.11.103
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!